According to Assertio Therapeutics 's latest financial reports the company's current earnings are HK$0.12 Billion. , an increase over its 2023 earnings that were of -HK$1.96 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | -HK$0.15 Billion | -92.46% |
2023 | -HK$1.96 Billion | -744.93% |
2022 | HK$0.30 B | 304.52% |
2021 | HK$74.87 M | -132.53% |
2020 | -HK$0.24 Billion | -81.97% |
2019 | -HK$1.28 Billion | -253.57% |
2018 | HK$0.83 B | -451.81% |
2017 | -HK$0.24 Billion | -258.05% |
2016 | HK$0.14 B | -138.59% |
2015 | -HK$0.39 Billion | -121.01% |
2014 | HK$1.84 B | 2275.01% |
2013 | HK$77.63 M | -133.45% |
2012 | -HK$0.24 Billion | -141.87% |
2011 | HK$0.55 B | 1496.17% |
2010 | HK$34.72 M | -121.23% |
2009 | -HK$0.17 Billion | 22.98% |
2008 | -HK$0.14 Billion | -135.96% |
2007 | HK$0.36 B | |
2003 | -HK$0.23 Billion | |
2000 | -HK$60.2 Million | 43.5% |
1999 | -HK$41.95 Million | 58.6% |
1998 | -HK$26.45 Million | 580% |
1997 | -HK$3.89 Million |